M.E

Doctoral degree in Science, Engineering or Masters Degree in Engineering or Technology from a recognized university or an equivalent Master degree with experience from industry, institution in the field of biotechnology, pharmaceutical.

M.Pharm or M.Sc in Biochemistry/ Biotechnology/ Microbiology/ Life Sciences. Towards discovery and development of novel drugs and pharmaceuticals Metastatic and Chemoresistant Breast Cancer Stem Cells

B.Pharma, M.Pharma; National Center for Disease Informatics and Research, NCDIR is one of its kind of unique institution which utilizes information science for health research as its integral component.

Ph.D. in Life Sciences, Biotechnology, Biochemistry, or a closely related discipline, focusing on proteomics, mass spectrometry, or systems biology. Ph.D. will be considered 4 years experience irrespective of the duration taken to complete the degree. MPH, M. Tech, ME, M. Pharma will not be considered as any experience.

M.Pharma/ equivalent degree in any branch of Life Sciences; Investigating and translating genomic evidence for public health response to SARS- CoV-2

PhD, MD, MDS or equivalent degree OR MVSc, MPharm, ME, MTech, with three years of research, teaching and design and development experience, with at least one research paper in Science Citation Index journal

PhD in Science, Engineering, Technology or Masters Degree in Engineering or Technology from recognized university/institute Specialization in Biotechnology, Bioprocessing, Biochemical Engineering, Chemical Engineering, Biochemistry, Chemistry or relevant area with two years’ experience

Ph.D. in Chemical Engineering, Biochemical Engineering, Environmental Engineering, Biochemistry, Biotechnology, Chemistry from a recognized University, Institute and having at least one research paper in Science Citation Indexed journal.

Project Development of Process for Montelukast KSM. Doctoral Degree in Chemical, Pharmaceutical Science, Pharma, MS from a recognized University or equivalent.